Aarti Pharmalabs Limited (NSE:AARTIPHARM)
India · Delayed Price · Currency is INR 850.80
+14.05 (1.68%)
Oct 16, 2025, 12:31 PM IST
Aarti Pharmalabs Revenue
Aarti Pharmalabs had revenue of 3.86B INR in the quarter ending June 30, 2025, a decrease of -30.48%. This brings the company's revenue in the last twelve months to 19.46B, down -0.20% year-over-year. In the fiscal year ending March 31, 2025, Aarti Pharmalabs had annual revenue of 21.15B with 14.17% growth.
Revenue (ttm)
19.46B
Revenue Growth
-0.20%
P/S Ratio
3.90
Revenue / Employee
9.00M
Employees
2,162
Market Cap
75.84B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 21.15B | 2.62B | 14.17% |
| Mar 31, 2024 | 18.53B | -926.24M | -4.76% |
| Mar 31, 2023 | 19.45B | 7.45B | 62.11% |
| Mar 31, 2022 | 12.00B | - | - |
| Mar 31, 2021 | - | - | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 537.77B |
| Divi's Laboratories | 96.52B |
| Cipla | 274.80B |
| Apollo Hospitals Enterprise | 225.51B |
| Mankind Pharma | 129.10B |
| Zydus Lifesciences | 236.08B |
| Fortis Healthcare | 80.94B |
| Aurobindo Pharma | 320.25B |